Year | 2012 | 2017 | 2040 | 2060 | Cumulativea | |
---|---|---|---|---|---|---|
Male | ||||||
No-NVP scenariob | Smokers | 32.1% | 29.1% | 22.5% | 20.6% | – |
SADs | 111,909 | 108,729 | 99,458 | 86,383 | 4,956,100 | |
LYLs | 1,171,679 | 1,189,823 | 890,229 | 671,585 | 46,425,200 | |
NVP Scenarioc | Smokers | 32.1% | 27.4% | 18.1% | 16.6% | – |
NVP users | 0.0% | 1.3% | 4.4% | 5.5% | – | |
FS-NVP users | 0.0% | 0.8% | 1.3% | 0.5% | – | |
SVADs | 111,909 | 107,342 | 94,707 | 79,977 | 4,757,770 | |
LYLs | 1,171,679 | 1,164,455 | 805,087 | 567,618 | 42,904,963 | |
Net impactd | Deaths averted | 0 | 1386 | 4751 | 6406 | 198,330 |
LYLs averted | 0 | 25,367 | 85,142 | 103,967 | 3,520,237 | |
Female | ||||||
No-NVP scenariob | Smokers | 24.7% | 22.6% | 17.7% | 16.1% | – |
SADs | 52,058 | 45,517 | 44,666 | 40,169 | 2,195,568 | |
LYLs | 440,936 | 441,049 | 369,645 | 267,812 | 18,462,657 | |
NVP Scenarioc | Smokers | 24.7% | 21.5% | 15.0% | 13.4% | – |
NVP users | 0.0% | 0.7% | 2.8% | 3.9% | – | |
FS-NVP users | 0.0% | 0.55% | 0.8% | 0.3% | – | |
SVADs | 52,058 | 44,611 | 42,352 | 37,872 | 2,101,907 | |
LYLs | 440,936 | 429,620 | 340,489 | 237,606 | 17,247,469 | |
Net impactd | Deaths averted | 0 | 906 | 2314 | 2296 | 93,661 |
LYLs averted | 0 | 11,428 | 29,156 | 30,206 | 1,215,187 | |
Both genders | ||||||
Net impactd | Deaths averted | 0 | 2292 | 7065 | 8702 | 291,991 |
LYLs averted | 0 | 36,795 | 114,298 | 134,173 | 4,735,424 | |
Deaths averted | 0.0% | 1.5% | 4.9% | 6.9% | 4.1% | |
LYLs averted | 0.0% | 2.3% | 9.1% | 14.3% | 7.3% |